Cargando…
Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists
New quinazoline-sulfonylurea hybrids were prepared and examined for their in vivo anti-hyperglycemic activities in STZ-induced hyperglycemic rats using glibenclamide as a reference drug. Compounds VI-6-a, V, IV-4, VI-4-c, IV-6, VI-2-a, IV-1, and IV-2 were more potent than the reference glibenclamide...
Autores principales: | El-Zahabi, Mohamed Ayman, Bamanie, Faida H., Ghareeb, Salah, Alshaeri, Heba K., Alasmari, Moudi M., Moustafa, Mohamed, Al-Marzooki, Zohair, Zayed, Mohamed F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455857/ https://www.ncbi.nlm.nih.gov/pubmed/36077003 http://dx.doi.org/10.3390/ijms23179605 |
Ejemplares similares
-
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs
por: Mabrouk, Reda R., et al.
Publicado: (2023) -
Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones
por: Lee, Kyeong Won, et al.
Publicado: (2011) -
Sulfonylurea Receptor 1 Expression in Human Cerebral Infarcts
por: Mehta, Rupal I., et al.
Publicado: (2013) -
Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015) -
Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)